Effect of tocilizumab in hospitalized patients with severe pneumonia COVID-19: a cohort study
Benjamin Rossi, View ORCID ProfileLee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, Helene Guillot, Marie-Anne Bouldouyre, View ORCID ProfileYves Allenbach, Joe-Elie Salem, Paul Barsoum, Arezki Oufella, Helene Gros
doi: https://doi.org/10.1101/2020.06.06.20122341
Benjamin Rossi
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Lee S. Nguyen
2Research & innovation of CMC Ambroise Paré, 92200 Neuilly-sur-Seine, France
3Sorbonne Université, INSERM, Clinical Investigations Center Paris-Est, CIC-1901, AP.HP.6 Pitié-Salpétrière, 75013 Paris, France
Philippe Zimmermann
4Department of pharmacy, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Faiza Boucenna
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Louis Dubret
4Department of pharmacy, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Louise Baucher
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Helene Guillot
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Marie-Anne Bouldouyre
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Yves Allenbach
5Sorbonne Université, Department of Internal medicine and Clinical Immunology, AP.HP.6 Pitié-Salpétrière, 75013 Paris, France
Joe-Elie Salem
3Sorbonne Université, INSERM, Clinical Investigations Center Paris-Est, CIC-1901, AP.HP.6 Pitié-Salpétrière, 75013 Paris, France
Paul Barsoum
6Department of cardiology, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Arezki Oufella
4Department of pharmacy, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Helene Gros
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Data Availability
data are not available
Posted June 09, 2020.
Effect of tocilizumab in hospitalized patients with severe pneumonia COVID-19: a cohort study
Benjamin Rossi, Lee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, Helene Guillot, Marie-Anne Bouldouyre, Yves Allenbach, Joe-Elie Salem, Paul Barsoum, Arezki Oufella, Helene Gros
medRxiv 2020.06.06.20122341; doi: https://doi.org/10.1101/2020.06.06.20122341
Effect of tocilizumab in hospitalized patients with severe pneumonia COVID-19: a cohort study
Benjamin Rossi, Lee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, Helene Guillot, Marie-Anne Bouldouyre, Yves Allenbach, Joe-Elie Salem, Paul Barsoum, Arezki Oufella, Helene Gros
medRxiv 2020.06.06.20122341; doi: https://doi.org/10.1101/2020.06.06.20122341
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (625)
- Anesthesia (162)
- Cardiovascular Medicine (2341)
- Dermatology (205)
- Emergency Medicine (376)
- Epidemiology (11713)
- Forensic Medicine (10)
- Gastroenterology (696)
- Genetic and Genomic Medicine (3698)
- Geriatric Medicine (347)
- Health Economics (632)
- Health Informatics (2377)
- Health Policy (928)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3458)
- Nursing (195)
- Nutrition (520)
- Oncology (1805)
- Ophthalmology (534)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (416)
- Public and Global Health (6096)
- Radiology and Imaging (1263)
- Respiratory Medicine (822)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (397)
- Toxicology (50)
- Transplantation (171)
- Urology (145)